Semax / Selank is a dual-peptide research formulation combining two synthetic peptides studied extensively in laboratory models involving neurological signaling, neurotransmitter activity, neurotrophic pathways, and cellular communication within the central nervous system. Because the peptides originate from different biological sequences and have been investigated across distinct neurological pathways, the combination provides a multi-component format for controlled neuroscience research.

Semax is a seven-amino-acid peptide derived from a fragment of adrenocorticotropic hormone (ACTH). Laboratory research has explored its relationship with neurotrophic signaling, including pathways associated with brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), as well as neuronal plasticity, neurotransmitter activity, and cellular responses to neurological stress.

Selank is a seven-amino-acid synthetic analog derived from the naturally occurring peptide tuftsin. Research has examined its relationship with GABAergic, serotonergic, and other neurotransmitter systems, along with pathways associated with gene expression, neuronal communication, and neuroendocrine signaling.

This formulation combines 15mg Semax and 15mg Selank and is supplied in a nasal research format for controlled laboratory investigation involving neurotrophic signaling, neurotransmitter systems, neuronal communication, and related neurological pathways.